2002

Dec 19, 2002
Guidant Receives CE Mark Approval for the MULTI-LINK VISION Cobalt Chromium Coronary Stent System

Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company has received...

Dec 17, 2002
Guidant Completes Enrollment in Clinical Trial to Study Carotid Artery Stenting as Alternative Treatment for High Surgical-Risk Patients

Study Will Evaluate Potential New Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Dec 11, 2002
Guidant Acquires Cardiac Intelligence Corporation

Strategic Acquisition will Enhance Company Initiative to Enable Remote, Wireless Monitoring of Heart Function in Patients with Implanted Devices Indianapolis, Ind. - Guidant Corporation (NYSE and...

Dec 6, 2002
Guidant Appoints Guido J. Neels Group Chairman, Office of the President

Neels to Direct Guidant''s Worldwide Sales and Distribution Operations Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Nov 27, 2002
Guidant Comments on Cook-Boston Scientific Litigation

Court of Appeals Denies Stay of Injunction; Cook to Move Forward with Appeal Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Nov 25, 2002
Guidant Applauds HHS Advisory Committee's Regulatory Reform Recommendations

Reforms to Promote Patient Access to Advanced Medical Technologies Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Nov 22, 2002
Guidant Invests in Developer of Minimally Invasive Devices for Treatment of Lung Disease

Spiration''s Solutions Represent Potential New Treatments for Emphysema and Lung Cancer Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Nov 21, 2002
Landmark Heart Failure Therapy Study Sponsored by Guidant Achieves Primary Endpoint

COMPANION Study Stopped Due to Significant Reduction in Combined All-Cause Mortality and All-Cause Hospitalization Cardiac Resynchronization Therapy Defibrillator Arm Demonstrated Significant...

Nov 20, 2002
National Coverage Decision for Implantable Defibrillators Referred to Medicare Coverage Advisory Committee

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today reported that the Center for Medicare and Medicaid Services...

Nov 18, 2002
Guidant Introduces Innovative Next-Generation Stabilization Platform for Beating Heart Surgery

New System Designed to Simplify the Beating Heart Procedure Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Show per page

Top